Tycho Peterson
Stock Analyst at Jefferies
(4.60)
# 252
Out of 4,761 analysts
130
Total ratings
64.84%
Success rate
17.42%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $249.85 | +16.07% | 2 | Feb 6, 2025 | |
| DHR Danaher | Maintains: Buy | $285 → $260 | $210.23 | +23.67% | 1 | Jan 29, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $11.10 | +98.20% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $172.24 | +7.41% | 1 | Dec 10, 2024 | |
| QDEL QuidelOrtho | Initiates: Hold | $43 | $40.46 | +6.28% | 5 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $64.49 | +31.80% | 7 | Dec 10, 2024 | |
| QGEN Qiagen | Assumes: Buy | $43 → $56 | $39.57 | +40.56% | 5 | Dec 10, 2024 | |
| WAT Waters | Upgrades: Buy | $355 → $415 | $374.82 | +10.72% | 7 | Oct 8, 2024 | |
| TWST Twist Bioscience | Maintains: Underweight | $28 → $35 | $41.31 | -15.27% | 3 | Aug 5, 2024 | |
| RVTY Revvity | Maintains: Hold | $115 → $125 | $113.84 | +9.80% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $10.90 | +120.18% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.54 | +159.74% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $1.54 | +94.81% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $162.31 | -12.51% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $42.87 | -25.36% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $94.20 | +22.08% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $14.18 | +41.04% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $532.55 | +22.05% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $1,230 → $1,250 | $1,286.54 | -2.84% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $13.52 | -33.43% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.21 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.26 | +430.97% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $7.55 | +694.70% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.07 | +465.11% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $900 | $20.01 | +4,397.75% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $163.02 | +139.23% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $150 | $135.37 | +10.81% | 7 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $2.05 | +1,021.95% | 1 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.80 | +373.68% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $591.79 | -66.20% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $20.87 | +15.00% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $18.75 | +140.00% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $160 | $1.19 | +13,345.38% | 4 | Sep 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $158.99 | -55.97% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $191.04 | -37.19% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.11 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $50.82 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $16.51 | +233.13% | 1 | Jul 19, 2016 |
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $249.85
Upside: +16.07%
Danaher
Jan 29, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $210.23
Upside: +23.67%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $11.10
Upside: +98.20%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $172.24
Upside: +7.41%
QuidelOrtho
Dec 10, 2024
Initiates: Hold
Price Target: $43
Current: $40.46
Upside: +6.28%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $64.49
Upside: +31.80%
Qiagen
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $39.57
Upside: +40.56%
Waters
Oct 8, 2024
Upgrades: Buy
Price Target: $355 → $415
Current: $374.82
Upside: +10.72%
Twist Bioscience
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $41.31
Upside: -15.27%
Revvity
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $113.84
Upside: +9.80%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $10.90
Upside: +120.18%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.54
Upside: +159.74%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $1.54
Upside: +94.81%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $162.31
Upside: -12.51%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $42.87
Upside: -25.36%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $94.20
Upside: +22.08%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $14.18
Upside: +41.04%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $532.55
Upside: +22.05%
Jun 3, 2024
Assumes: Underperform
Price Target: $1,230 → $1,250
Current: $1,286.54
Upside: -2.84%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $13.52
Upside: -33.43%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.21
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.26
Upside: +430.97%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $7.55
Upside: +694.70%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.07
Upside: +465.11%
Jun 21, 2021
Initiates: Overweight
Price Target: $900
Current: $20.01
Upside: +4,397.75%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $163.02
Upside: +139.23%
May 26, 2021
Maintains: Overweight
Price Target: $140 → $150
Current: $135.37
Upside: +10.81%
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $2.05
Upside: +1,021.95%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.80
Upside: +373.68%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $591.79
Upside: -66.20%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $20.87
Upside: +15.00%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $18.75
Upside: +140.00%
Sep 27, 2019
Downgrades: Underweight
Price Target: $160
Current: $1.19
Upside: +13,345.38%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $158.99
Upside: -55.97%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $191.04
Upside: -37.19%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.11
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $50.82
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $16.51
Upside: +233.13%